Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Methods1 from Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study
  1. Home
  2. Publications
  3. Supplementary Methods1 from Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study

Supplementary Methods1 from Rilvegostomig for Metastatic Non–Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study

Authors:
  • KRKristoffer S. Rohrberg
    Kristoffer S. Rohrberg
  • MBMariana Brandão
    Mariana Brandão
  • EÁEduardo Castañón Álvarez
    Eduardo Castañón Álvarez
  • EFEnriqueta Felip
    Enriqueta Felip
  • EGEelke Gort
    Eelke Gort
  • THT. Jeroen N. Hiltermann
    T. Jeroen N. Hiltermann
  • HIHiroki Izumi
    Hiroki Izumi
  • DKDong-Wan Kim
    Dong-Wan Kim
  • SKSang-We Kim
    Sang-We Kim
  • LPLuis Paz-Ares
    Luis Paz-Ares
  • BSBenjamin Solomon
    Benjamin Solomon
  • ESEgbert F. Smit
    Egbert F. Smit

Open Access
Publisher website
Google Scholar
  • 15 October 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.34520348
Abstract
Supplementary Methods and Materials.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • PHASE II CLINICAL TRIALS
  • LUNG CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.